Clinical Trial Update: IMPACT 360 for Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for IMPACT 360 in Parkinson's disease and REM sleep behavior disorder. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Rem Sleep Behavior Disorder

Drugs mentioned

• IMPACT 360

Snippet

Sponsor: University of British Columbia | Conditions: Parkinson's Disease (PD), REM Sleep Behavior Disorder | Phase 2 | Status: RECRUITING